Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology

References

• Akao Y, Iio A, Itoh T, Noguchi S, Itoh Y, Ohtsuki Y et al. Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol Ther 2011;19:395–399.
   PubMed Web of Science ®Google Scholar
• Baigude H, Rana TM. Interfering nanoparticles for silencing microRNAs. Meth Enzymol 2012;509:339–353.
   PubMed Web of Science ®Google Scholar
• Barber GN. Cytoplasmic DNA innate immune pathways. Immunol Rev 2011;243:99–108.
   PubMed Web of Science ®Google Scholar
• Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009;324:1710–1713.
   PubMed Web of Science ®Google Scholar
• Boon RA, Seeger T, Heydt S, Fischer A, Hergenreider E, Horrevoets AJ et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res 2011;109:1115–1119.
   PubMed Web of Science ®Google Scholar
• Bostjancic E, Zidar N, Glavac D. MicroRNA microarray expression profiling in human myocardial infarction. Dis Markers 2009;27:255–268.
   PubMed Web of Science ®Google Scholar
• Bot I, de Jager SC, Zernecke A, Lindstedt KA, van Berkel TJ, Weber C et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 2007;115:2516–2525.
   PubMed Web of Science ®Google Scholar
• Broderick JA, Zamore PD. MicroRNA therapeutics. Gene Ther 2011;18:1104–1110.
   PubMed Web of Science ®Google Scholar
• Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009;119:2772–2786.
   PubMed Web of Science ®Google Scholar
• Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007;13:613–618.
   PubMed Web of Science ®Google Scholar
• Caporali A, Meloni M, Völlenkle C, Bonci D, Sala-Newby GB, Addis R et al. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 2011;123:282–291.
   PubMed Web of Science ®Google Scholar
• Chan LS, Yue PY, Mak NK, Wong RN. Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis. Eur J Pharm Sci 2009;38:370–377.
   PubMed Web of Science ®Google Scholar
• Chen T, Huang Z, Wang L, Wang Y, Wu F, Meng S et al. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res 2009;83:131–139.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Zhou SH. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway. Cardiol J 2011;18:675–681.
   PubMed Web of Science ®Google Scholar
• Chen J, Yin H, Jiang Y, Radhakrishnan SK, Huang ZP, Li J et al. Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler Thromb Vasc Biol 2011a;31:368–375.
   PubMed Web of Science ®Google Scholar
• Chen T, Li Z, Tu J, Zhu W, Ge J, Zheng X et al. MicroRNA-29a regulates pro-inflammatory cytokine secretion and scavenger receptor expression by targeting LPL in oxLDL-stimulated dendritic cells. FEBS Lett 2011b;585:657–663.
   PubMed Web of Science ®Google Scholar
• Chen T, Li Z, Jing T, Zhu W, Ge J, Zheng X et al. MicroRNA-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cells. FEBS Lett 2011c;585:567–573.
   PubMed Web of Science ®Google Scholar
• Chen H, Untiveros GM, McKee LA, Perez J, Li J, Antin PB et al. Micro-RNA-195 and -451 regulate the LKB1/AMPK signaling axis by targeting MO25. PLoS ONE 2012;7:e41574.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009;105:158–166.
   PubMed Web of Science ®Google Scholar
• Cingolani E, Ramirez Correa GA, Kizana E, Murata M, Cho HC, Marbán E. Gene therapy to inhibit the calcium channel β subunit: physiological consequences and pathophysiological effects in models of cardiac hypertrophy. Circ Res 2007;101:166–175.
   PubMed Web of Science ®Google Scholar
• Cocucci E, Racchetti G, Rupnik M, Meldolesi J. The regulated exocytosis of enlargeosomes is mediated by a SNARE machinery that includes VAMP4. J Cell Sci 2008;121:2983–2991.
   PubMed Web of Science ®Google Scholar
• Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009;460:705–710.
   PubMed Web of Science ®Google Scholar
• Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 2012;110:483–495.
   PubMed Web of Science ®Google Scholar
• da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, el Azzouzi H et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 2010;12:1220–1227.
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 2012;161:505–522.
   PubMed Web of Science ®Google Scholar
• Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D, Brizzi MF. microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol 2010;30:1562–1568.
   PubMed Web of Science ®Google Scholar
• Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007;110:2440–2448.
   PubMed Web of Science ®Google Scholar
• Dong DL, Chen C, Huo R, Wang N, Li Z, Tu YJ et al. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension 2010;55:946–952.
   PubMed Web of Science ®Google Scholar
• Dorn GW 2nd. MicroRNAs: redefining mechanisms in cardiac disease. J Cardiovasc Pharmacol 2010;56:589–595.
   PubMed Web of Science ®Google Scholar
• Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009;104:170–178, 6p following 178.
   PubMed Web of Science ®Google Scholar
• Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007;4:721–726.
   PubMed Web of Science ®Google Scholar
• Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008;452:896–899.
   PubMed Web of Science ®Google Scholar
• Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006;3:87–98.
   PubMed Web of Science ®Google Scholar
• Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci USA 2010;107:13450–13455.
   PubMed Web of Science ®Google Scholar
• Fang J, Song XW, Tian J, Chen HY, Li DF, Wang JF et al. Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 2012;17:410–423.
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 2006;58:1456–1459.
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010;107:677–684.
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, Zeiher AM, Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 2011;31:2383–2390.
   PubMed Web of Science ®Google Scholar
• Fiedler J, Jazbutyte V, Kirchmaier BC, Gupta SK, Lorenzen J, Hartmann D et al. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 2011;124:720–730.
   PubMed Web of Science ®Google Scholar
• Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008;15:272–284.
   PubMed Web of Science ®Google Scholar
• Geisler A, Jungmann A, Kurreck J, Poller W, Katus HA, Vetter R et al. microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors. Gene Ther 2011;18:199–209.
   PubMed Web of Science ®Google Scholar
• Glass C, Singla DK. MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart. Am J Physiol Heart Circ Physiol 2011;301:H2038–H2049.
   PubMed Web of Science ®Google Scholar
• Grieger JC, Samulski RJ. Adeno-associated virus vectorology, manufacturing, and clinical applications. Meth Enzymol 2012;507:229–254.
   PubMed Web of Science ®Google Scholar
• Grünweller A, Hartmann RK. Locked nucleic acid oligonucleotides: the next generation of antisense agents? BioDrugs 2007;21:235–243.
   PubMed Web of Science ®Google Scholar
• Günther M, Lipka J, Malek A, Gutsch D, Kreyling W, Aigner A. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Eur J Pharm Biopharm 2011;77:438–449.
   PubMed Web of Science ®Google Scholar
• Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL et al. Prevention of cardiac hypertrophy and heart failure by silencing of NF-κB. J Mol Biol 2008;375:637–649.
   PubMed Web of Science ®Google Scholar
• Gupta S, Maitra R, Young D, Gupta A, Sen S. Silencing the myotrophin gene by RNA interference leads to the regression of cardiac hypertrophy. Am J Physiol Heart Circ Physiol 2009;297:H627–H636.
   PubMed Web of Science ®Google Scholar
• Gwinn MR, Vallyathan V. Nanoparticles: health effects–pros and cons. Environ Health Perspect 2006;114:1818–1825.
   PubMed Web of Science ®Google Scholar
• Ibrahim AF, Weirauch U, Thomas M, Grünweller A, Hartmann RK, Aigner A. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 2011;71:5214–5224.
   PubMed Web of Science ®Google Scholar
• Ikeda S, He A, Kong SW, Lu J, Bejar R, Bodyak N et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol 2009;29:2193–2204.
   PubMed Web of Science ®Google Scholar
• Haraguchi T, Ozaki Y, Iba H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res 2009;37:e43.
   PubMed Web of Science ®Google Scholar
• Haraguchi T, Nakano H, Tagawa T, Ohki T, Ueno Y, Yoshida T et al. A potent 2′-O-methylated RNA-based microRNA inhibitor with unique secondary structures. Nucleic Acids Res 2012;40:e58.
   PubMed Web of Science ®Google Scholar
• Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJ, Zeiher AM et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012;14:249–256.
   PubMed Web of Science ®Google Scholar
• Hong S, Kim KY, Wook HJ, Park SY, Lee KD, Lee, DY, Lee H. Attenuation of the in vivo toxicity of biomaterials by polydopamine surface modification. Biomaterials 2011;32:2241–2247.
   PubMedGoogle Scholar
• Horie T, Ono K, Nishi H, Iwanaga Y, Nagao K, Kinoshita M et al. MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes. Biochem Biophys Res Commun 2009;389:315–320.
   PubMed Web of Science ®Google Scholar
• Hu S, Huang M, Nguyen PK, Gong Y, Li Z, Jia F et al. Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation. Circulation 2011;124:S27–S34.
   PubMed Web of Science ®Google Scholar
• Huang RS, Hu GQ, Lin B, Lin ZY, Sun CC. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J Investig Med 2010;58:961–967.
   PubMed Web of Science ®Google Scholar
• Jentzsch C, Leierseder S, Loyer X, Flohrschütz I, Sassi Y, Hartmann D et al. A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. J Mol Cell Cardiol 2012;52:13–20.
   Google Scholar
• Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007;100:1579–1588.
   PubMed Web of Science ®Google Scholar
• Kim HI, Ishihara K, Lee S, Seo JH, Kim HY, Suh D et al. Tissue response to poly(L-lactic acid)-based blend with phospholipid polymer for biodegradable cardiovascular stents. Biomaterials 2011;32:2241–2247.
   PubMed Web of Science ®Google Scholar
• Kim HW, Choi YH, Kang SM, Ku JY, Ahn JH, Kim JM et al. Malignant inflammatory myofibroblastic tumor of the bladder with rapid progression. Korean J Urol 2012;53:657–661.
   PubMedGoogle Scholar
• Knuefermann P, Baumgarten G, Koch A, Schwederski M, Velten M, Ehrentraut H et al. CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo. Respir Res 2007;8:72.
   PubMedGoogle Scholar
• Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 2005;438:685–689.
   PubMed Web of Science ®Google Scholar
• Lai EC. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002;30:363–364.
   PubMed Web of Science ®Google Scholar
• Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010;327:198–201.
   PubMed Web of Science ®Google Scholar
• Leroyer AS, Isobe H, Lesèche G, Castier Y, Wassef M, Mallat Z et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007;49:772–777.
   PubMed Web of Science ®Google Scholar
• Liang GF, Zhu YL, Sun B, Hu FH, Tian T, Li SC et al. PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells. Nanoscale Res Lett 2011;6:447.
   PubMedGoogle Scholar
• Love KT, Mahon KP, Levins CG, Whitehead KA, Querbes W, Dorkin JR et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci USA 2010;107:1864–1869.
   PubMed Web of Science ®Google Scholar
• Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009;104:476–487.
   PubMed Web of Science ®Google Scholar
• Liu J, van Mil A, Vrijsen K, Zhao J, Gao L, Metz CH et al. MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. J Cell Mol Med 2011;15:1474–1482.
   Google Scholar
• Loo YM, Gale M Jr. Immune signaling by RIG-I-like receptors. Immunity 2011;34:680–692.
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang F et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 2010;122:2378–2387.
   PubMed Web of Science ®Google Scholar
• Manilla P, Rebello T, Afable C, Lu X, Slepushkin V, Humeau LM et al. Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther 2005;16:17–25.
   PubMed Web of Science ®Google Scholar
• Marik J, Tartis MS, Zhang H, Fung JY, Kheirolomoom A, Sutcliffe JL et al. Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP). Nucl Med Biol 2007;34:165–171.
   PubMed Web of Science ®Google Scholar
• Mendrick DL. Transcriptional profiling to identify biomarkers of disease and drug response. Pharmacogenomics 2011;12:235–249.
   PubMed Web of Science ®Google Scholar
• Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010;328:1566–1569.
   PubMed Web of Science ®Google Scholar
• Patrick DM, Montgomery RL, Qi X, Obad S, Kauppinen S, Hill JA et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 2010;120:3912–3916.
   PubMed Web of Science ®Google Scholar
• O’Riordan CR, Song A. PEGylated adenovirus for targeted gene therapy. Methods Mol Biol 2008;434:133–160.
   PubMedGoogle Scholar
• Porrello ER, Johnson BA, Aurora AB, Simpson E, Nam YJ, Matkovich SJ et al. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ Res 2011;109:670–679.
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Suárez Y, Dávalos A, Parathath S, Fitzgerald ML, Tamehiro N et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010;328:1570–1573.
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, van Gils JM et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011a;478:404–407.
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest 2011b;121:2921–2931.
   PubMed Web of Science ®Google Scholar
• Ramirez CM, Dávalos A, Goedeke L, Salerno AG, Warrier N, Cirera-Salinas D et al. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 2011;31:2707–2714.
   PubMed Web of Science ®Google Scholar
• Ranghino A, Cantaluppi V, Grange C, Vitillo L, Fop F, Biancone L et al. Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia. Int J Immunopathol Pharmacol 2012;25:75–85.
   PubMed Web of Science ®Google Scholar
• Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009;119:2357–2366.
   PubMed Web of Science ®Google Scholar
• Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 2009;82:21–29.
   PubMed Web of Science ®Google Scholar
• Sacco J, Adeli K. MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol 2012;23:220–225.
   PubMed Web of Science ®Google Scholar
• Salic K, De Windt LJ. MicroRNAs as biomarkers for myocardial infarction. Curr Atheroscler Rep 2012;14:193–200.
   PubMed Web of Science ®Google Scholar
• Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H et al. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 2008;19:3272–3282.
   PubMed Web of Science ®Google Scholar
• SCENIHR. (2007). The scientific aspects of the existing and proposed definitions relating to products of nanoscience and nanotechnologies. 2007. Available at http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_012.pdf
   Google Scholar
• Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, Cho CK et al. Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 2010;28:172–176.
   PubMed Web of Science ®Google Scholar
• Singha K, Namgung R, Kim WJ. Polymers in small-interfering RNA delivery. Nucleic Acid Ther 2011;21:133–147.
   PubMed Web of Science ®Google Scholar
• Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai B et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009;83:465–472.
   PubMed Web of Science ®Google Scholar
• Shan ZX, Lin QX, Deng CY, Zhu JN, Mai LP, Liu JL et al. miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. FEBS Lett 2010;584:3592–3600.
   PubMed Web of Science ®Google Scholar
• Tang Y, Zheng J, Sun Y, Wu Z, Liu Z, Huang G. MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J 2009;50:377–387.
   PubMed Web of Science ®Google Scholar
• Tano N, Kim HW, Ashraf M. microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4. PLoS ONE 2011;6:e23114.
   PubMedGoogle Scholar
• Tasaka S, Kamata H, Miyamoto K, Nakano Y, Shinoda H, Kimizuka Y et al. Intratracheal synthetic CpG oligodeoxynucleotide causes acute lung injury with systemic inflammatory response. Respir Res 2009;10:84.
   PubMedGoogle Scholar
• Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 2007;42:1137–1141.
   PubMed Web of Science ®Google Scholar
• Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci 2007;95:300–312.
   PubMed Web of Science ®Google Scholar
• Terentyev D, Belevych AE, Terentyeva R, Martin MM, Malana GE, Kuhn DE et al. miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56α and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ Res 2009;104:514–521.
   PubMed Web of Science ®Google Scholar
• Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980–984.
   PubMed Web of Science ®Google Scholar
• Thum T, Chau N, Bhat B, Gupta SK, Linsley PS, Bauersachs J et al. Comparison of different miR-21 inhibitor chemistries in a cardiac disease model. J Clin Invest 2011;121:461–462; author reply 462.
   PubMed Web of Science ®Google Scholar
• van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007;316:575–579.
   PubMed Web of Science ®Google Scholar
• van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008;105:13027–13032.
   PubMed Web of Science ®Google Scholar
• van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med 2009;13:1577–1585.
   PubMed Web of Science ®Google Scholar
• Vasir JK, Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Deliv Rev 2007;59:718–728.
   PubMed Web of Science ®Google Scholar
• Vetrini F, Ng P. Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives. Viruses 2010;2:1886–1917.
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011;13:423–433.
   PubMed Web of Science ®Google Scholar
• Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008;15:261–271.
   PubMed Web of Science ®Google Scholar
• Weber M, Baker MB, Moore JP, Searles CD. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun 2010;393:643–648.
   PubMed Web of Science ®Google Scholar
• Wickline SA, Neubauer AM, Winter P, Caruthers S, Lanza G. Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology. Arterioscler Thromb Vasc Biol 2006;26:435–441.
   PubMed Web of Science ®Google Scholar
• Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007a;131:146–159.
   PubMed Web of Science ®Google Scholar
• Xiao J, Luo X, Lin H, Zhang Y, Lu Y, Wang N, Zhang Y, Yang B, Wang Z. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 2007b;282:12363−12367.
   PubMed Web of Science ®Google Scholar
• Xie J, Xie Q, Zhang H, Ameres SL, Hung JH, Su Q et al. MicroRNA-regulated, systemically delivered rAAV9: a step closer to CNS-restricted transgene expression. Mol Ther 2011;19:526–535.
   PubMed Web of Science ®Google Scholar
• Xie J, Ameres SL, Friedline R, Hung JH, Zhang Y, Xie Q et al. Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nat Methods 2012;9:403–409.
   PubMed Web of Science ®Google Scholar
• Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 2007;120:3045–3052.
   PubMed Web of Science ®Google Scholar
• Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007;13:486–491.
   PubMed Web of Science ®Google Scholar
• Yang K, He YS, Wang XQ, Lu L, Chen QJ, Liu J et al. MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett 2011;585:854–860.
   PubMed Web of Science ®Google Scholar
• Yang Y, Ago T, Zhai P, Abdellatif M, Sadoshima J. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7. Circ Res 2011;108:305–313.
   PubMed Web of Science ®Google Scholar
• Yao XL, Nakagawa S, Gao JQ. Current targeting strategies for adenovirus vectors in cancer gene therapy. Curr Cancer Drug Targets 2011;11:810–825.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010;107:810–817.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Mayr M. MicroRNAs in vascular and metabolic disease. Circ Res 2012;110:508–522.
   PubMed Web of Science ®Google Scholar
• Zernecke A, Schober A, Bot I, von Hundelshausen P, Liehn EA, Möpps B et al. SDF-1α/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005;96:784–791.
   PubMed Web of Science ®Google Scholar
• Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009;2:ra81.
   PubMed Web of Science ®Google Scholar
• Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, Meiler S et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2008;102:209–217.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010;39:133–144.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007;129:303–317.
   PubMed Web of Science ®Google Scholar
• Zidar N, Boštjancic E, Glavac D, Stajer D. MicroRNAs, innate immunity and ventricular rupture in human myocardial infarction. Dis Markers 2011;31:259–265.
   PubMed Web of Science ®Google Scholar